{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T20:51:38Z","timestamp":1773953498003,"version":"3.50.1"},"reference-count":56,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2015,3,8]],"date-time":"2015-03-08T00:00:00Z","timestamp":1425772800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,3,8]],"date-time":"2015-03-08T00:00:00Z","timestamp":1425772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["K01CA114252"],"award-info":[{"award-number":["K01CA114252"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"crossref","award":["RSG-07-218-01-TBE"],"award-info":[{"award-number":["RSG-07-218-01-TBE"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"crossref","award":["W81XWH-12-1-0112"],"award-info":[{"award-number":["W81XWH-12-1-0112"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"crossref","award":["W81XWH-12-1-0275"],"award-info":[{"award-number":["W81XWH-12-1-0275"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81272851"],"award-info":[{"award-number":["81272851"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30973587"],"award-info":[{"award-number":["30973587"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81102383"],"award-info":[{"award-number":["81102383"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81302206"],"award-info":[{"award-number":["81302206"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81302226"],"award-info":[{"award-number":["81302226"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81430087"],"award-info":[{"award-number":["81430087"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jilin Provincial Science and Technology Department of China","award":["20130101164JC"],"award-info":[{"award-number":["20130101164JC"]}]},{"name":"Jilin Provincial Education Department of China","award":["2013191"],"award-info":[{"award-number":["2013191"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostate"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1002\/pros.22987","type":"journal-article","created":{"date-parts":[[2015,3,9]],"date-time":"2015-03-09T01:50:49Z","timestamp":1425865849000},"page":"1001-1008","source":"Crossref","is-referenced-by-count":8,"title":["Methylselenocysteine preventing castration-resistant progression of prostate cancer"],"prefix":"10.1002","volume":"75","author":[{"given":"Yanbo","family":"Liu","sequence":"first","affiliation":[{"name":"Basic Medical College; Beihua University; Jilin China"},{"name":"College of Basic Medical Sciences; Jilin University; Changchun China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xichun","family":"Liu","sequence":"additional","affiliation":[{"name":"College of Basic Medical Sciences; Jilin University; Changchun China"},{"name":"Department of Pathology and Laboratory Medicine; Tulane University School of Medicine; Tulane Cancer Center; New Orleans Louisiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaxiong","family":"Guo","sequence":"additional","affiliation":[{"name":"College of Basic Medical Sciences; Jilin University; Changchun China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuowen","family":"Liang","sequence":"additional","affiliation":[{"name":"College of Basic Medical Sciences; Jilin University; Changchun China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Tian","sequence":"additional","affiliation":[{"name":"College of Basic Medical Sciences; Jilin University; Changchun China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Lu","sequence":"additional","affiliation":[{"name":"Basic Medical College; Beihua University; Jilin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Zhao","sequence":"additional","affiliation":[{"name":"Basic Medical College; Beihua University; Jilin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[{"name":"Basic Medical College; Beihua University; Jilin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejian","family":"Zhao","sequence":"additional","affiliation":[{"name":"College of Basic Medical Sciences; Jilin University; Changchun China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine; Tulane University School of Medicine; Tulane Cancer Center; New Orleans Louisiana"},{"name":"College of Life Sciences; Jilin University; Changchun China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Dong","sequence":"additional","affiliation":[{"name":"College of Life Sciences; Jilin University; Changchun China"},{"name":"National Engineering Laboratory for AIDS Vaccine; Jilin University; Changchun China"},{"name":"Department of Structural and Cellular Biology; Tulane University School of Medicine; Tulane Cancer Center; New Orleans Louisiana"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,3,8]]},"reference":[{"key":"10.1002\/pros.22987-BIB0001|pros22987-cit-0001","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1210\/me.2010-0469","article-title":"Minireview: Alternative activation pathways for the androgen receptor in prostate cancer","volume":"25","author":"Lamont","year":"2011","journal-title":"Mol Endocrinol"},{"key":"10.1002\/pros.22987-BIB0002|pros22987-cit-0002","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ctrv.2013.09.011","article-title":"Castration-resistant prostate cancer: Adaptive responses in the androgen axis","volume":"40","author":"Egan","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"10.1002\/pros.22987-BIB0003|pros22987-cit-0003","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1158\/1078-0432.CCR-08-2660","article-title":"Starving the addiction: New opportunities for durable suppression of AR signaling in prostate cancer","volume":"15","author":"Knudsen","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1002\/pros.22987-BIB0004|pros22987-cit-0004","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/76287","article-title":"Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor","volume":"6","author":"Zhao","year":"2000","journal-title":"Nat Med"},{"key":"10.1002\/pros.22987-BIB0005|pros22987-cit-0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/(SICI)1097-0045(19980401)35:1<63::AID-PROS9>3.0.CO;2-I","article-title":"Expression, structure, and function of androgen receptor in advanced prostatic carcinoma","volume":"35","author":"Culig","year":"1998","journal-title":"Prostate"},{"key":"10.1002\/pros.22987-BIB0006|pros22987-cit-0006","first-page":"314","article-title":"Androgen receptor gene amplification: A possible molecular mechanism for androgen deprivation therapy failure in prostate cancer","volume":"57","author":"Koivisto","year":"1997","journal-title":"Cancer Res"},{"key":"10.1002\/pros.22987-BIB0007|pros22987-cit-0007","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ng0495-401","article-title":"In vivo amplification of the androgen receptor gene and progression of human prostate cancer","volume":"9","author":"Visakorpi","year":"1995","journal-title":"Nat Genet"},{"key":"10.1002\/pros.22987-BIB0008|pros22987-cit-0008","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.1158\/0008-5472.CAN-07-5997","article-title":"Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer","volume":"68","author":"Locke","year":"2008","journal-title":"Cancer Res"},{"key":"10.1002\/pros.22987-BIB0009|pros22987-cit-0009","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1158\/0008-5472.CAN-08-0249","article-title":"Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth","volume":"68","author":"Montgomery","year":"2008","journal-title":"Cancer Res"},{"key":"10.1002\/pros.22987-BIB0010|pros22987-cit-0010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nm972","article-title":"Molecular determinants of resistance to antiandrogen therapy","volume":"10","author":"Chen","year":"2004","journal-title":"Nat Med"},{"key":"10.1002\/pros.22987-BIB0011|pros22987-cit-0011","first-page":"149","article-title":"Novel mutations of androgen receptor: A possible mechanism of bicalutamide withdrawal syndrome","volume":"63","author":"Hara","year":"2003","journal-title":"Cancer Res"},{"key":"10.1002\/pros.22987-BIB0012|pros22987-cit-0012","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0960-0760(92)90401-4","article-title":"The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens","volume":"41","author":"Veldscholte","year":"1992","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1002\/pros.22987-BIB0013|pros22987-cit-0013","doi-asserted-by":"crossref","first-page":"9611","DOI":"10.1158\/0008-5472.CAN-05-0817","article-title":"Antiandrogen bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient","volume":"65","author":"Yoshida","year":"2005","journal-title":"Cancer Res"},{"key":"10.1002\/pros.22987-BIB0014|pros22987-cit-0014","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.1158\/0008-5472.CAN-08-0594","article-title":"Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance","volume":"68","author":"Dehm","year":"2008","journal-title":"Cancer Res"},{"key":"10.1002\/pros.22987-BIB0015|pros22987-cit-0015","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1158\/0008-5472.CAN-08-3795","article-title":"A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth","volume":"69","author":"Guo","year":"2009","journal-title":"Cancer Res"},{"key":"10.1002\/pros.22987-BIB0016|pros22987-cit-0016","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1158\/0008-5472.CAN-08-2764","article-title":"Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer","volume":"69","author":"Hu","year":"2009","journal-title":"Cancer Res"},{"key":"10.1002\/pros.22987-BIB0017|pros22987-cit-0017","first-page":"6606","article-title":"Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line","volume":"62","author":"Tepper","year":"2002","journal-title":"Cancer Res"},{"key":"10.1002\/pros.22987-BIB0018|pros22987-cit-0018","doi-asserted-by":"crossref","first-page":"8141","DOI":"10.1158\/0008-5472.CAN-09-0919","article-title":"Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens","volume":"69","author":"Waltering","year":"2009","journal-title":"Cancer Res"},{"key":"10.1002\/pros.22987-BIB0019|pros22987-cit-0019","doi-asserted-by":"crossref","first-page":"10613","DOI":"10.1158\/0008-5472.CAN-06-0028","article-title":"Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression","volume":"66","author":"Cheng","year":"2006","journal-title":"Cancer Res"},{"key":"10.1002\/pros.22987-BIB0020|pros22987-cit-0020","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/pros.20329","article-title":"Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA)","volume":"66","author":"Lee","year":"2006","journal-title":"Prostate"},{"key":"10.1002\/pros.22987-BIB0021|pros22987-cit-0021","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1002\/ijc.28202","article-title":"Methylselenol prodrug enhances MDV3100 efficacy for treatment of castration-resistant prostate cancer","volume":"133","author":"Zhan","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1002\/pros.22987-BIB0022|pros22987-cit-0022","first-page":"2882","article-title":"In vitro and in vivo studies of methylseleninic acid: Evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention","volume":"60","author":"Ip","year":"2000","journal-title":"Cancer Res"},{"key":"10.1002\/pros.22987-BIB0023|pros22987-cit-0023","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/jn\/128.11.1845","article-title":"Lessons from basic research in selenium and cancer prevention","volume":"128","author":"Ip","year":"1998","journal-title":"J Nutr"},{"key":"10.1002\/pros.22987-BIB0024|pros22987-cit-0024","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/carcin\/bgn007","article-title":"Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite","volume":"29","author":"Li","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1002\/pros.22987-BIB0025|pros22987-cit-0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.2008.864","article-title":"Effect of selenium and vitamin E on risk of prostate cancer and other cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)","volume":"301","author":"Lippman","year":"2009","journal-title":"JAMA"},{"key":"10.1002\/pros.22987-BIB0026|pros22987-cit-0026","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1158\/1940-6207.CAPR-08-0173","article-title":"Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit","volume":"2","author":"Wang","year":"2009","journal-title":"Cancer Prev Res (Phila Pa)"},{"key":"10.1002\/pros.22987-BIB0027|pros22987-cit-0027","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1021\/tx900202m","article-title":"Speciation analysis of selenium metabolites in urine and breath by HPLC- and GC-inductively coupled plasma-MS after administration of selenomethionine and methylselenocysteine to rats","volume":"22","author":"Ohta","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1002\/pros.22987-BIB0028|pros22987-cit-0028","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1158\/1940-6207.CAPR-10-0259","article-title":"Methyl selenocysteine: Single-dose pharmacokinetics in men","volume":"4","author":"Marshall","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1002\/pros.22987-BIB0029|pros22987-cit-0029","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1158\/1078-0432.CCR-03-0268","article-title":"Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts","volume":"10","author":"Cao","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1002\/pros.22987-BIB0030|pros22987-cit-0030","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1158\/1535-7163.MCT-08-0908","article-title":"In vivo molecular mediators of cancer growth suppression and apoptosis by selenium in mammary and prostate models: Lack of involvement of gadd genes","volume":"8","author":"Jiang","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1002\/pros.22987-BIB0031|pros22987-cit-0031","first-page":"1598","article-title":"Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors","volume":"52","author":"Gleave","year":"1992","journal-title":"Cancer Res"},{"key":"10.1002\/pros.22987-BIB0032|pros22987-cit-0032","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/ijc.27754","article-title":"20(S)-protopanaxadiol-aglycone downregulation of the full-length and splice variants of androgen receptor","volume":"132","author":"Cao","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1002\/pros.22987-BIB0033|pros22987-cit-0033","doi-asserted-by":"crossref","first-page":"R56","DOI":"10.1186\/bcr2615","article-title":"ImmunoRatio: A publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67","volume":"12","author":"Tuominen","year":"2010","journal-title":"Breast Cancer Res"},{"key":"10.1002\/pros.22987-BIB0034|pros22987-cit-0034","first-page":"115","article-title":"The LNCaP cell line-A new model for studies on human prostatic carcinoma","volume":"37","author":"Horoszewicz","year":"1980","journal-title":"Prog Clin Biol Res"},{"key":"10.1002\/pros.22987-BIB0035|pros22987-cit-0035","first-page":"4146","article-title":"The suppression of human prostate tumor growth in mice by the intratumoral injection of a slow-release polymeric paste formulation of paclitaxel","volume":"60","author":"Jackson","year":"2000","journal-title":"Cancer Res"},{"key":"10.1002\/pros.22987-BIB0036|pros22987-cit-0036","first-page":"3058","article-title":"Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models","volume":"60","author":"Miyake","year":"2000","journal-title":"Cancer Res"},{"key":"10.1002\/pros.22987-BIB0037|pros22987-cit-0037","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1158\/1078-0432.CCR-10-3077","article-title":"A novel HSP90 inhibitor delays castrate-resistant prostate cancer without altering serum PSA levels and inhibits osteoclastogenesis","volume":"17","author":"Lamoureux","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1002\/pros.22987-BIB0038|pros22987-cit-0038","doi-asserted-by":"crossref","first-page":"5754","DOI":"10.1158\/0008-5472.CAN-10-2470","article-title":"Insulin increases de novo steroidogenesis in prostate cancer cells","volume":"71","author":"Lubik","year":"2011","journal-title":"Cancer Res"},{"key":"10.1002\/pros.22987-BIB0039|pros22987-cit-0039","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1002\/ijc.26287","article-title":"Carbidopa abrogates L-dopa decarboxylase coactivation of the androgen receptor and delays prostate tumor progression","volume":"130","author":"Wafa","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1002\/pros.22987-BIB0040|pros22987-cit-0040","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/cncr.25477","article-title":"Screening, risk assessment, and the approach to therapy in patients with prostate cancer","volume":"117","author":"Freedland","year":"2011","journal-title":"Cancer"},{"key":"10.1002\/pros.22987-BIB0041|pros22987-cit-0041","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/pros.21472","article-title":"Castration resistant prostate cancer is associated with increased blood vessel stabilization and elevated levels of VEGF and Ang-2","volume":"72","author":"Tomic","year":"2012","journal-title":"Prostate"},{"key":"10.1002\/pros.22987-BIB0042|pros22987-cit-0042","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/jcb.10728","article-title":"Chemoprevention of prostate cancer with selenium: An update on current clinical trials and preclinical findings","volume":"91","author":"Meuillet","year":"2004","journal-title":"J Cell Biochem"},{"key":"10.1002\/pros.22987-BIB0043|pros22987-cit-0043","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/jnci\/djh125","article-title":"A prospective study of plasma selenium levels and prostate cancer risk","volume":"96","author":"Li","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/pros.22987-BIB0044|pros22987-cit-0044","volume-title":"Dietary reference intakes: Vitamin C, Vitamin E, selenium, and carotenoids","author":"Institute of Medicine FaNB","year":"2000"},{"key":"10.1002\/pros.22987-BIB0045|pros22987-cit-0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jtemb.2004.03.004","article-title":"A report of high-dose selenium supplementation: Response and toxicities","volume":"18","author":"Reid","year":"2004","journal-title":"J Trace Elem Med Biol"},{"key":"10.1002\/pros.22987-BIB0046|pros22987-cit-0046","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.1158\/1078-0432.CCR-11-0728","article-title":"Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: Induction of steroidogenesis and androgen receptor splice variants","volume":"17","author":"Mostaghel","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1002\/pros.22987-BIB0047|pros22987-cit-0047","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMoa1315815","article-title":"AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer","volume":"371","author":"Antonarakis","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1002\/pros.22987-BIB0048|pros22987-cit-0048","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.18632\/oncotarget.1802","article-title":"Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy","volume":"5","author":"Cao","year":"2014","journal-title":"Oncotarget"},{"key":"10.1002\/pros.22987-BIB0049|pros22987-cit-0049","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1158\/0008-5472.CAN-12-3630","article-title":"Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines","volume":"73","author":"Li","year":"2012","journal-title":"Cancer Res"},{"key":"10.1002\/pros.22987-BIB0050|pros22987-cit-0050","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1172\/JCI41824","article-title":"Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant","volume":"120","author":"Sun","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1002\/pros.22987-BIB0051|pros22987-cit-0051","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1158\/1535-7163.MCT-10-0985","article-title":"Berberine suppresses androgen receptor signaling in prostate cancer","volume":"10","author":"Li","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1002\/pros.22987-BIB0052|pros22987-cit-0052","doi-asserted-by":"crossref","first-page":"e31213","DOI":"10.1371\/journal.pone.0031213","article-title":"Kava components down-regulate expression of AR and AR splice variants and reduce growth in patient-derived prostate cancer xenografts in mice","volume":"7","author":"Li","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1002\/pros.22987-BIB0053|pros22987-cit-0053","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1124\/mol.110.064790","article-title":"Pharmacological targeting of constitutively active truncated androgen receptor by nigericin and suppression of hormone-refractory prostate cancer cell growth","volume":"78","author":"Mashima","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1002\/pros.22987-BIB0054|pros22987-cit-0054","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.4161\/cc.8.24.10316","article-title":"Small molecule screening reveals a transcription-independent pro-survival function of androgen receptor in castration-resistant prostate cancer","volume":"8","author":"Narizhneva","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1002\/pros.22987-BIB0055|pros22987-cit-0055","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1593\/neo.111436","article-title":"ASC-J9 suppresses castration-resistant prostate cancer growth through degradation of full-length and splice variant androgen receptors","volume":"14","author":"Yamashita","year":"2012","journal-title":"Neoplasia"},{"key":"10.1002\/pros.22987-BIB0056|pros22987-cit-0056","doi-asserted-by":"crossref","first-page":"11530","DOI":"10.3390\/ijms130911530","article-title":"Effects of sorafenib on C-terminally truncated androgen receptor variants in human prostate cancer cells","volume":"13","author":"Zengerling","year":"2012","journal-title":"Int J Mol Sci"}],"container-title":["The Prostate"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpros.22987","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpros.22987","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/pros.22987\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T04:50:54Z","timestamp":1625460654000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pros.22987"}},"subtitle":["MSC Inhibition of Castration Resistance"],"short-title":[],"issued":{"date-parts":[[2015,3,8]]},"references-count":56,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,6]]}},"URL":"https:\/\/doi.org\/10.1002\/pros.22987","archive":["Portico"],"relation":{},"ISSN":["0270-4137"],"issn-type":[{"value":"0270-4137","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3,8]]}}}